GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹91 Cr | ₹64 Cr | ₹39 Cr | ₹40 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 41.76 | |
| Mar2024 | ₹64 Cr | 62.66 | |
| Mar2023 | ₹39 Cr | -2.08 | |
| Mar2022 | ₹40 Cr | 282.80 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,652.6 Cr | 7% | -1.7% | 31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 7% |
-1.7% |
31.4% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses